Pharmaceutical Eltrombopag Powder Cas 496775-61-2

Unit Price:	95~108 USD
Payment Type:	T/T,L/C,D/P,D/A,Paypal,Others
Incoterm:	DDP,CIP,CPT,FCA,CIF,EXW,CFR,FOB,DDU,Express Delivery,DEQ,DAF,DES
Min. Order:	1 Kilogram

 Pharmaceutical Eltrombopag Powder Cas 496775-61-2

Basic Info

Model No.: Pharmaceutical Eltrombopag

Brand: quanao

MOQ: 1 Kg

Specification: 99%

Particle Size: 100% Pass 80 Mesh

Shelf Life: 2 Years

Appearance: White Powder

Test Method: HPLC

Product Name: Eltrombopag

Ingredients: Eltrombopag

Source: Eltrombopag

Additional Info

Packaging: packed in: 1kg with double plastic container inside/Aluminum foil bag outside. 25kg with double plastic container inside/Fiber drum outside.

Productivity: 50T/Month

Transportation: Ocean,Land,Air,Express,Others

Place of Origin: China,xi'an

Supply Ability: 50T/Month

Certificate: organinc,halal,iso

HS Code: 391239000

Port: Shanghai,Ningbo,Tianjin

Payment Type: T/T,L/C,D/P,D/A,Paypal,Others

Incoterm: DDP,CIP,CPT,FCA,CIF,EXW,CFR,FOB,DDU,Express Delivery,DEQ,DAF,DES

Product Description

Active Pharmaceutical Ingredients Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Medicine Raw Material Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manufactured and marketed by GlaxoSmithKline under the trade name Promacta in the USA and is marketed as Revolade in the EU.

Pharmaceutical Eltrombopag Powder Cas 496775-61-2

Product Description